Hall Eric S, Wexelblatt Scott L, Greenberg James M
1 Perinatal Institute, Cincinnati Children's Hospital Medical Center , Cincinnati, Ohio.
2 Department of Pediatrics, University of Cincinnati College of Medicine , Cincinnati, Ohio.
Popul Health Manag. 2018 Dec;21(6):486-492. doi: 10.1089/pop.2017.0184. Epub 2018 Feb 27.
The objective was to use population-based electronic health records for surveillance of intrauterine exposures to substances of abuse, including opioids, and to monitor changes in exposure rates over time. This retrospective, descriptive analysis utilized geocoded neonatal physician billing records representing intrauterine exposures to substances of abuse detected through universal maternal drug testing. Census tract-level exposure rates were identified among the newborn population of Hamilton County, Ohio between 2014 and 2016. Among 27,896 newborns, the authors detected an intrauterine opioid exposure rate of 37.9 per 1000 infants, with 10.5 per 1000 experiencing severe opioid withdrawal (neonatal abstinence syndrome). Individual data were mapped to 222 US census tracts. Tract-level opioid exposure rates ranged from 0.0 to 607.1 (median: 32.9) per 1000 live births. Secondary use of electronic health record data has potential to aid in intrauterine opioid exposure and other public health surveillance efforts without disrupting clinical workflows or placing an additional burden on limited resources. Surveillance of intrauterine opioid exposures may inform stakeholders and enable targeting of interventions and prevention strategies toward the highest risk populations.
目的是利用基于人群的电子健康记录监测子宫内药物滥用暴露情况,包括阿片类药物,并监测暴露率随时间的变化。这项回顾性描述性分析利用了地理编码的新生儿医生计费记录,这些记录代表了通过普遍的孕产妇药物检测发现的子宫内药物滥用暴露情况。在2014年至2016年期间,确定了俄亥俄州汉密尔顿县新生儿人群中的普查区层面暴露率。在27896名新生儿中,作者检测到每1000名婴儿中有37.9例子宫内阿片类药物暴露,每1000名中有10.5例经历严重阿片类药物戒断(新生儿戒断综合征)。个体数据被映射到222个美国普查区。普查区层面的阿片类药物暴露率范围为每1000例活产0.0至607.1(中位数:32.9)。电子健康记录数据的二次使用有潜力帮助进行子宫内阿片类药物暴露及其他公共卫生监测工作,而不会扰乱临床工作流程或给有限资源带来额外负担。子宫内阿片类药物暴露监测可为利益相关者提供信息,并使干预措施和预防策略能够针对风险最高的人群。